Measles Update for Travelers

Interim Clinical Considerations for Use of COVID-19 Vaccines in the United States (CDC)

Clinical Guidance - DC DOH Resources

Summary of recent changes (last updated September 6, 2024):

  • Recommendations for the use of 2024–2025 Novavax COVID-19 Vaccine in people ages 12 years and older
  • Updated guidance in the Interchangeability of COVID-19 vaccines section and in Appendix B on completion of an initial vaccination series if vaccine doses from different manufacturers are administered in certain circumstances
Learn More

Source: CDC

Related Topics

Protect Yourself and Your Community This Holiday Season: A Message to the Black Community

Protect Yourself and Your Community This Holiday Season: A Message to the...Read More

Living Well DC

Living Well DC The health of DC residents is important. Everyone in...Read More

Interim Clinical Considerations for Use of COVID-19 Vaccines in the United States (CDC)

Summary of recent changes (last updated September 6, 2024): Recommendations for the...Read More